Continuing Education Company Primary Care On Demand: Diabetes Volume 3 (2023)
Practical Updates in Type 2 Diabetes, Cardiometabolic Care & Kidney Disease Management
Primary Care On Demand: Diabetes Volume 3 (2023) is a comprehensive online educational program designed to help primary care clinicians stay current with the rapidly evolving field of diabetes management. Developed by Continuing Education Company, this course delivers evidence-based guidance on modern diabetes treatment strategies, cardiometabolic risk reduction, chronic kidney disease prevention, and the latest pharmacologic advances.
Focused on real-world clinical practice, the program reviews current diabetes guidelines, pathophysiology-based treatment approaches, and emerging therapies including SGLT2 inhibitors, GLP-1 receptor agonists, and dual incretin receptor agonists. Through practical case discussions and expert-led lectures, participants gain actionable knowledge that can be immediately applied in family medicine and primary care settings.
Product Details
- Course: Primary Care On Demand: Diabetes Volume 3
- Provider: Continuing Education Company
- Course Year: 2023
- Format: Online Video Course
- Includes: 12 Video Lectures + 12 PDF Handouts
- Target Audience: Primary Care and Family Medicine Clinicians
Program Overview
This course highlights the latest science and evidence-based practices in diabetes care.
Major topics include:
- Type 2 Diabetes Guidelines
- Diabetes Pathophysiology
- SGLT2 Inhibitors
- GLP-1 Receptor Agonists
- Dual Incretin Therapies
- Resistant Hypertension
- Diabetic Kidney Disease
- Cardiorenal Protection
- Cardiometabolic Medicine
- Diabetes in Older Adults
- Chronic Kidney Disease
- Individualized Treatment Strategies
The curriculum focuses on translating current research into practical clinical decision-making.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Develop effective assessment and monitoring strategies for patients with diabetes.
- Apply current evidence-based diabetes guidelines in daily practice.
- Formulate individualized treatment plans based on patient-specific risk factors.
- Integrate cardiometabolic and renal risk reduction strategies into diabetes care.
- Utilize modern pharmacologic therapies appropriately and effectively.
- Improve long-term outcomes through early intervention and prevention strategies.
- Address complex diabetes cases involving cardiovascular and kidney disease.
- Optimize management of older adults with diabetes and multiple comorbidities.
Core Topics Covered
Type 2 Diabetes Guidelines
Participants review:
- Current diagnostic criteria
- Glycemic targets
- Risk stratification
- Individualized treatment planning
- Evidence-based guideline recommendations
Practical implementation strategies are emphasized throughout the course.
Pathophysiology-Based Treatment
Sessions explore:
- Insulin resistance
- Beta-cell dysfunction
- Metabolic pathways
- Disease progression
- Personalized treatment selection
Clinicians learn how disease mechanisms influence therapeutic choices.
SGLT2 Inhibitors
Comprehensive coverage includes:
- Mechanism of action
- Cardiovascular benefits
- Renal protection
- Clinical indications
- Safety considerations
Faculty review landmark clinical trials and practical prescribing strategies.
GLP-1 Receptor Agonists
Topics include:
- Weight reduction benefits
- Glycemic control
- Cardiovascular risk reduction
- Patient selection
- Treatment optimization
Current evidence supporting GLP-1 therapy is discussed in detail.
Dual Incretin Therapies
Participants learn about:
- Emerging therapeutic agents
- Comparative effectiveness
- Weight loss outcomes
- Metabolic benefits
- Future treatment directions
The course reviews how these agents are reshaping diabetes care.
Resistant Hypertension
Important updates cover:
- Novel treatment options
- Secondary causes
- Cardiovascular risk management
- Combination therapy approaches
Strategies for difficult-to-control blood pressure are highlighted.
Cardiorenal Disease
Sessions focus on:
- Diabetes-related kidney disease
- Cardiorenal syndrome
- Risk reduction strategies
- Early intervention
- Long-term outcome improvement
Participants learn practical approaches to preserving renal function.
Diabetes in Older Adults
Special considerations include:
- Individualized glycemic goals
- Polypharmacy management
- Frailty assessment
- Cardiovascular risk reduction
- Treatment safety
The course emphasizes patient-centered decision-making.
Case-Based Learning
Interactive clinical cases explore:
- Complex diabetes management
- Kidney disease progression
- Cardiovascular complications
- Treatment intensification
- Medication selection
Real-world examples reinforce key learning points.
Educational Features
✔ Expert-Led Video Lectures
✔ Evidence-Based Clinical Updates
✔ Practical Case Discussions
✔ Current Diabetes Guidelines
✔ Cardiometabolic Disease Management
✔ Kidney Disease Prevention Strategies
✔ Downloadable PDF Handouts
✔ Self-Paced Online Learning
Target Audience
This course is ideal for:
- Family Medicine Physicians
- Primary Care Physicians
- Internal Medicine Physicians
- Nurse Practitioners
- Physician Assistants
- Advanced Practice Providers
- Community-Based Clinicians
- Healthcare Professionals Managing Diabetes
Why This Course Stands Out
✔ Focused specifically on diabetes management in primary care
✔ Covers the latest evidence-based treatment guidelines
✔ Strong emphasis on cardiometabolic and renal protection
✔ Practical application for everyday clinical practice
✔ Reviews modern therapies including GLP-1 and SGLT2 agents
✔ Addresses complex patients with multiple comorbidities
✔ Case-based approach enhances clinical decision-making
✔ Flexible on-demand learning format
Clinical & Educational Value
Primary Care On Demand: Diabetes Volume 3 (2023) provides a practical and clinically relevant review of modern diabetes care. Through expert-led instruction, evidence-based recommendations, and real-world case discussions, participants gain the knowledge and confidence needed to optimize diabetes management, reduce cardiovascular and renal complications, and improve long-term patient outcomes in primary care practice.
+ Topics:| Session | Title | Faculty |
| Session 1 (47 minutes) | Type 2 Diabetes Guidelines | S. Inzucchi, MD |
| Session 2 (44 minutes) | Treatment of Type 2 Diabetes: A Sound Approach Based on Its Pathophysiology | J. Buse, MD, PhD |
| Session 3 (44 minutes) | Practical Aspects of Using Newer Diabetes Medications: SGLT2 Inhibitors and GLP-1 Receptor Agonists | S. Inzucchi, MD |
| Session 4 (49 minutes) | Type 2 Diabetes: What Have the Latest Trials on Older Drugs Told Us? | J. Buse, MD, PhD |
| Session 5 (63 minutes) | Cases in Diabetes | J. Buse, MD, PhD & S. Inzucchi, MD |
| Session 6 (62 minutes) | Contrasting the GLP-1 and Dual Incretin Receptor Agonists with SGLT2 Inhibitors in the Early Treatment of Diabetes | M. McDonnell, MD |
| Session 7 (46 minutes) | Novel Medications for Resistant Hypertension: What the Future Holds | G. Bakris, MD |
| Session 8 (47 minutes) | Selecting Therapies in the Older Outpatient with Diabetes: A Cardiometabolic Approach | M. McDonnell, MD |
| Session 9 (58 minutes) | “Pillars of Therapy”: The 21st Century Approach to Halting Nephropathy from Diabetes | G. Bakris, MD |
| Session 10 (81 minutes) | Cases in Diabetes, Kidney, and Cardio-Renal Disease | M. McDonnell, MD & G. Bakris, MD |
